187 related articles for article (PubMed ID: 10037385)
1. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?
Stoevelaar HJ; Van de Beek C; Casparie AF; McDonnell J; Nijs HG
J Urol; 1999 Jan; 161(1):133-8. PubMed ID: 10037385
[TBL] [Abstract][Full Text] [Related]
2. [Variation in the diagnosis and treatment of benign prostatic hyperplasia in urological practice].
Stoevelaar HJ; van de Beek C; Casparie AF; Nijs HG; McDonnell J; Janknegt RA
Ned Tijdschr Geneeskd; 1996 Apr; 140(15):837-42. PubMed ID: 8668278
[TBL] [Abstract][Full Text] [Related]
3. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
[TBL] [Abstract][Full Text] [Related]
4. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
DiSantostefano RL; Biddle AK; Lavelle JP
BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
[TBL] [Abstract][Full Text] [Related]
6. [Clinical questionnaires about benign prostatic hyperplasia].
Zhang XH; Li X; Ye ZQ; Sun ZY; Sun YH; Sun G; Wang JY; Na YQ
Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1153-5. PubMed ID: 19094678
[TBL] [Abstract][Full Text] [Related]
7. [Benign prostatic hyperplasia. Shared care between urologists and general practitioners].
Talseth T; Hedlund H
Tidsskr Nor Laegeforen; 1997 Jan; 117(3):389-93. PubMed ID: 9064864
[TBL] [Abstract][Full Text] [Related]
8. [Data analysis of the objective observation parameters of benign prostatic hyperplasia patients accepting different treatment regimens].
Zhang YG; Wang JY; Liu M; Wan B; Wei D; Deng SM; Xu J; Wu JY; Chu X; Zeng P
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1690-2. PubMed ID: 19024540
[TBL] [Abstract][Full Text] [Related]
9. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia: a review.
Ramsey EW
Can J Urol; 2000 Dec; 7(6):1135-43. PubMed ID: 11151094
[TBL] [Abstract][Full Text] [Related]
11. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic and therapeutic management of the benign prostatic hyperplasia by the general practitioners in the Maine-et-Loire].
Bigot P; Vannier F; Orsat M; Lebdai S; Huez JF; Fanello S; Azzouzi AR
Prog Urol; 2010 Jan; 20(1):65-70. PubMed ID: 20123530
[TBL] [Abstract][Full Text] [Related]
13. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
Seftel A; Rosen R; Kuritzky L
Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
[TBL] [Abstract][Full Text] [Related]
14. An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia.
Black L; Naslund MJ; Gilbert TD; Davis EA; Ollendorf DA
Am J Manag Care; 2006 Mar; 12(4 Suppl):S99-S110. PubMed ID: 16551208
[TBL] [Abstract][Full Text] [Related]
15. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
Seftel AD; Rosen RC; Rosenberg MT; Sadovsky R
Int J Clin Pract; 2008 Apr; 62(4):614-22. PubMed ID: 18266709
[TBL] [Abstract][Full Text] [Related]
16. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
Nichol MB; Knight TK; Wu J; Barron R; Penson DF
J Urol; 2009 May; 181(5):2214-21; discussion 2221-2. PubMed ID: 19296986
[TBL] [Abstract][Full Text] [Related]
17. [The urologist and prostatic disease. National survey. Members of the Spanish Council of Prostatic Health].
Jiménez Cruz JF; Rodríguez Vallejo JM; Conejero J; Resel L; Rioja Sanz LA; Vela Navarrete R; Vicente J
Actas Urol Esp; 1996; 20(7):630-5. PubMed ID: 8975548
[TBL] [Abstract][Full Text] [Related]
18. [Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations. Results of a french survey involving patients treated with finasteride].
Teillac P
Therapie; 2002; 57(5):473-83. PubMed ID: 12611202
[TBL] [Abstract][Full Text] [Related]
19. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of benign prostatic hyperplasia in general practice and practical approach of the Tunisian general practitioner (Prevapt study)].
Horchani A; Binous MY; Ben Hamida A; Sallami S; El Adbi H; Naji A
Tunis Med; 2007 Aug; 85(8):619-24. PubMed ID: 18254279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
